Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
49.70Today’s High
55.0052W low
45.1052W High
81.30Open Price
51.30Prev. Close
49.0300Volume
201662.00Value
10375509.90Fundamentals
Market Cap
51.30
Price to Earnings
68.30
Price to Book Value
1.00
Dividend Yield
0.00
PE to Growth
-30.20
Op Revenue TTM
27.93
Net Profit TTM
0.75
Cash From Operating Activity
-7.08
Return on Equity %
1.48
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
68.3
Week
74.7
Month
80.5
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
52.03
PIVOT
First Resistance
54.37
Second Resistance
57.28
Third Resistance
59.62
First Support
49.12
Second Support
46.78
Third Support
43.87
Relative Strength Index
55.23
Money Flow Index
81.38
MACD
-0.3
MACD Signal
-0.53
Average True Range
3.19
Average Directional Index
11.21
Rate of Change (21)
2.41
Rate of Change (125)
-17.48
Commodity Channel Index
208.4
Williams %R
-40
BETA
1 Month
1.35
3 Month
0.57
1 Year
0.42
3 Year
-0.03
PRICE CHANGE ANALYSIS
↑ 4.26%
1 Week
Low
High
46.21
54.95
↑ 4.94%
1 Month
Low
High
46.21
54.95
↓ -5.51%
3 Months
Low
High
45.1
60
↓ -16.04%
6 Months
Low
High
45.1
81.32
↓ -23.79%
1 Year
Low
High
45.1
81.32
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 8.50 | 6.63 | 6.44 | 6.54 | 6.80 | 4.56 | 4.54 | 3.28 | 5.50 | 5.73 | 6.29 | |
| Operating Expenses Qtr | 7.88 | 6.15 | 6.06 | 6.23 | 6.23 | 4.05 | 4.17 | 2.92 | 5.04 | 5.53 | 5.65 | |
| Operating Profit Qtr | 0.52 | 0.46 | 0.36 | 0.28 | 0.36 | 0.32 | 0.15 | 0.12 | 0.25 | 0.05 | 0.44 | |
| EBIDT Qtr Cr | 0.63 | 0.48 | 0.38 | 0.30 | 0.57 | 0.51 | 0.37 | 0.36 | 0.45 | 0.20 | 0.64 | |
| Depreciation Qtr | 0.18 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.15 | 0.16 | |
| Net Profit Qtr | 0.31 | 0.24 | 0.12 | 0.08 | 0.28 | 0.25 | 0.15 | 0.08 | 0.15 | -0.06 | 0.22 | |
| Basic EPS Qtr | 0.28 | 0.24 | 0.12 | 0.10 | 0.34 | 0.31 | 0.18 | 0.10 | 0.18 | -0.07 | 0.15 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 28.11 | 19.18 | 26.09 | 12.45 | 0.43 | |
| Operating Expenses Annual Cr | 26.32 | 17.37 | 24.12 | 11.47 | 0.17 | |
| Operating Profit Annual | 1.61 | 0.95 | 1.30 | 0.52 | 0.24 | |
| Operating Profit Margin Annual % | 5.74 | 4.98 | 4.97 | 4.19 | 55.14 | |
| Total Expenses Annual Cr | 27.12 | 18.15 | 25.14 | 11.62 | 0.30 | |
| EBIDT Annual Cr | 1.79 | 1.81 | 1.97 | 0.98 | 0.26 | |
| EBIDT Annual margin % | 6.36 | 9.44 | 7.55 | 7.89 | 60.52 | |
| Depreciation | 0.66 | 0.63 | 0.56 | 0.06 | 0.06 | |
| PAT Before ExtraOrdinary Items Annual Cr | 0.75 | 0.77 | 0.71 | 0.61 | 0.13 | |
| Net Profit Annual | 0.75 | 0.77 | 0.71 | 0.61 | 0.13 | |
| Basic EPS Annual | 0.73 | 0.92 | 0.90 | 1.61 | 0.33 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 50.68 | 29.42 | 28.63 | 6.19 | 5.48 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 0.56 | 0.42 | 0.26 | 1.76 | 0.20 | |
| Total Current Liabilities Annual Cr | 1.50 | 1.20 | 6.01 | 2.33 | 0.08 | |
| Total Capital Plus Liabilities Annual Cr | 52.74 | 31.04 | 34.89 | 16.61 | 5.76 | |
| Fixed Assets Annual | 13.57 | 13.88 | 14.29 | 0.25 | 0.31 | |
| Total Non Current Assets Annual | 21.81 | 21.74 | 22.46 | 5.91 | 5.66 | |
| Total Current Assets Annual | 30.93 | 9.30 | 12.44 | 10.70 | 0.10 | |
| Total Assets Annual | 52.74 | 31.04 | 34.89 | 16.61 | 5.76 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -7.08 | 4.22 | -7.73 | -4.26 | 0.77 | |
| Cash from Investing Activity Annual | -0.55 | 0.87 | 0.59 | 0.50 | -0.65 | |
| Cash from Financing Annual Activity | 20.36 | -4.70 | 3.28 | 7.81 | -0.13 | |
| Net Cash Flow Annual | - | 0.40 | -3.85 | 4.05 | -0.01 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 39.37 | 35.38 | 34.42 | 16.19 | 14.35 | |
| ROE Annual % | 1.48 | 2.61 | 2.46 | 9.93 | 2.33 | |
| ROCE Annual % | 2.19 | 3.94 | 4.86 | 6.44 | 3.49 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.16 | 0.28 | 0.04 | |
| EBDIT Annual Margin % | 6.40 | 9.87 | 7.74 | 8.19 | 63.97 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Mar 2020 | Mar 2019 | Mar 2018 | Graph |
|---|---|---|---|---|
| Total Revenue Annual | 10.90 | 4.30 | 2.40 | |
| Operating Expenses Annual Cr | 15.31 | 4.96 | 1.99 | |
| Operating Profit Annual | -4.52 | -0.71 | 0.35 | |
| Operating Profit Margin Annual % | -41.45 | -16.53 | 14.47 | |
| Total Expenses Annual Cr | 15.84 | 5.30 | 2.16 | |
| EBIDT Annual Cr | -4.41 | -0.65 | 0.41 | |
| EBIDT Annual margin % | -40.41 | -15.17 | 17.16 | |
| Depreciation | 0.19 | 0.17 | 0.08 | |
| PAT Before ExtraOrdinary Items Annual Cr | -3.62 | -0.78 | 0.20 | |
| Net Profit Annual | -1.91 | -0.44 | 0.20 | |
| Basic EPS Annual | -4.99 | -1.16 | 0.63 |
| Indicator | Mar 2020 | Mar 2019 | Mar 2018 | Graph |
|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2.95 | 4.92 | 5.56 | |
| Minority Interest Liability Annual Cr | -1.83 | -0.12 | 0.22 | |
| Total Non Current Liabilities Annual Cr | 1.61 | 0.42 | 0.51 | |
| Total Current Liabilities Annual Cr | 9.33 | 4.08 | 4.66 | |
| Total Capital Plus Liabilities Annual Cr | 12.05 | 9.31 | 10.95 | |
| Fixed Assets Annual | 1.49 | 1.45 | 1.42 | |
| Total Non Current Assets Annual | 7.03 | 5.13 | 4.98 | |
| Total Current Assets Annual | 5.03 | 4.17 | 5.98 | |
| Total Assets Annual | 12.05 | 9.31 | 10.95 | |
| Contingent Liabilities plus Commitments Annual Cr | 0.00 | 0.00 | 0.00 |
| Indicator | Mar 2020 | Mar 2019 | Mar 2018 | Graph |
|---|---|---|---|---|
| Cash from Operating Activity Annual | -0.33 | 0.16 | 0.00 | |
| Cash from Investing Activity Annual | -0.71 | -0.30 | 0.00 | |
| Cash from Financing Annual Activity | 0.95 | -0.55 | 0.00 | |
| Net Cash Flow Annual | -0.09 | -0.69 | 0.00 |
| Indicator | Mar 2020 | Mar 2019 | Mar 2018 | Graph |
|---|---|---|---|---|
| Book Value Per Share Annual | 2.91 | 12.58 | 15.14 | |
| ROE Annual % | -64.71 | -9.02 | 3.52 | |
| ROCE Annual % | -168.96 | -15.76 | 5.25 | |
| Total Debt to Total Equity Annual | 0.55 | 0.28 | 0.31 | |
| EBDIT Annual Margin % | -40.83 | -15.37 | 17.63 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| LAXMIKANT KABRA (HUF) | 10.08 | 75282430 | 0 | 0 |
| BHAVESH DHIRAJLAL TANNA | 2.81 | 75282431 | 0 | 0 |
| LAXMIKANT RAMPRASAD KABRA | 0.84 | 75282432 | 0 | 0 |
| LENUS FINVEST PRIVATE LIMITED | 10.14 | 75282435 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| ASHOK VISHWANATH HIREMATH | 8.9 | 75282446 |
| ARITRO ASHISH ROY | 4.53 | 75282447 |
| KAUSHIK DAGA | 2.3 | 75282448 |
| SUSHILA PARASKUMAR DAGA | 1.72 | 75282449 |
| PARSHVA KUMAR DAGA | 1.71 | 75282450 |
| BHAVINKUMAR VINAYCHAND SHAH | 1.23 | 75282451 |
| DEEPAK JUGALKISHORE CHOKHANI | 1.2 | 75282452 |
| HUF | 1.74 | 75282438 |
| 2B BLACK BIO LLP . | 14.56 | 75282441 |
| ASHIKA GLOBAL FINANCE PVT. LTD. | 4.15 | 75282442 |
| V SQUARE PHARMACHEM PRIVATE LIMITED . | 1.22 | 75282443 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 20, 2017 | 0.25 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 13, 2024 | Audited Results | - |
| Feb 08, 2024 | Quarterly Results | - |
| Dec 14, 2023 | Others | Inter-alia, 1) Matter relating to payment of First and final call money on 55,44,178 partly paid-up equity shares of face value of Re. 10/- each which were issued and allotted on August 02, 2023. |
| Nov 08, 2023 | Quarterly Results | - |
| Jul 11, 2023 | Quarterly Results | - |
| Jun 30, 2023 | Right issue of Equity Shares | - |
| May 15, 2023 | Right issue of Equity Shares | - |
| May 09, 2023 | Audited Results | - |
| Jan 31, 2023 | Right issue of Equity Shares | - |
| Jan 17, 2023 | Quarterly Results | - |
| Oct 21, 2022 | Quarterly Results | - |
| Aug 12, 2022 | Quarterly Results | - |
| Apr 22, 2022 | Quarterly Results | - |
| Feb 08, 2022 | Quarterly Results | - |
| Nov 02, 2021 | Quarterly Results | - |
| Jul 30, 2021 | Quarterly Results | - |
| Apr 20, 2021 | Audited Results | - |
| Mar 01, 2021 | Preferential Issue of shares | - |
| Feb 10, 2021 | Quarterly Results | - |
| Nov 12, 2020 | Quarterly Results & Others | - |
| Oct 03, 2020 | Others | inter-alia, 1. Change in the main object of the Company to include manufacturing, marketing, import and export of Speciality and Fine Chemicals. |
| Sep 08, 2020 | Quarterly Results & A.G.M. | - |
| Jun 27, 2020 | Audited Results | - |
| Feb 13, 2020 | Quarterly Results | - |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 12, 2019 | Quarterly Results | - |
| May 29, 2019 | Audited Results | - |
| Jan 11, 2019 | Quarterly Results | - |
| Nov 02, 2018 | Quarterly Results | - |
| Aug 08, 2018 | Quarterly Results | - |
| May 11, 2018 | Audited Results | - |
| Feb 21, 2018 | Others | To consider allotment of shares on preferential Basis approved in EGM on 03.02.2018. |
| Jan 18, 2018 | Quarterly Results | - |
| Jan 04, 2018 | Preferential Issue of shares | - |
| Dec 28, 2017 | Preferential Issue of shares | - |
| Oct 05, 2017 | Others | - |
| Aug 12, 2017 | Quarterly Results | - |
| Apr 05, 2017 | Audited Results & Dividend | - |
| Jan 07, 2017 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
30 May 2024
Eiko Lifesciences Ltd - 540204 - Incorporation Of Limited Liability Partnership
Company has incorporated a Limited Liability Partnership namely Eiko Scientific Solutions LLP under LLPIN : ACH-4311
29 May 2024
Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF
24 May 2024
Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF
21 May 2024
Eiko Lifesciences Ltd - 540204 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of Regulation 24(A)of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Annual Compliance Report.
15 May 2024
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
13 May 2024
Eiko Lifesciences Ltd - 540204 - Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Statement on Deviation or Variation of funds under Regulation 32 of SEBI (LODR) Regulations, 2015
13 May 2024
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Secretarial Auditor
13 May 2024
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Internal Auditor
13 May 2024
Eiko Lifesciences Ltd - 540204 - Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2024 Along With Auditor'S Report Duly Signed By The Auditor Of The Company.
Audited Financial Results for quarter and year ended 31st march,2024
